Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Curevac N.V.

Start price
Target price
Perf. (%)
€95.29
09.02.21
€145.00
09.02.22
-62.48%
05.11.21

Very capable Management
Leading role in innovation
Some uniques
Growths much faster than the competition
SNDL Inc.

Start price
Target price
Perf. (%)
€13.50
09.02.21
€10.00
-9.63%
19.02.21

Probably not worthwhile Investment
High valuation
buy
Xpel Inc.

Start price
Target price
Perf. (%)
€47.20
09.02.21
-
09.02.22
11.23%
10.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€50.18
09.02.21
-
09.02.22
-14.31%
10.02.22

Could be very worthwhile Investment >20% year
Veru Inc

Start price
Target price
Perf. (%)
€17.90
09.02.21
-
09.02.22
-70.03%
10.02.22

Could be very worthwhile Investment >20% year
buy
Baader Bank AG

Start price
Target price
Perf. (%)
€10.00
09.02.21
€12.00
09.02.22
-28.00%
06.03.21

buy
Appian

Start price
Target price
Perf. (%)
€180.60
09.02.21
€110.00
09.02.22
-52.23%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
Increased challenges to pay loans and raise capital
buy
Dexcom Inc.

Start price
Target price
Perf. (%)
€82.24
09.02.21
€87.50
09.02.22
29.20%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Sustainability is important
Higher risks for its business
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€97.47
09.02.21
€100.00
-24.24%
13.03.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
Kion Group AG

Start price
Target price
Perf. (%)
€73.22
09.02.21
€82.00
09.02.22
11.94%
10.02.22

Could be worthwhile Investment >10% per year
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
buy
Clinuvel Pharmaceuticals

Start price
Target price
Perf. (%)
€13.90
09.02.21
-
09.02.22
10.47%
10.02.22

Fair valuation
Dependend from few customers or products
buy
Hamburger Hafen und Logistik AG

Start price
Target price
Perf. (%)
€18.56
09.02.21
€21.00
15.30%
09.03.21

Top 10 in its market
High risks for its business
Probably not worthwhile Investment
Revenue decline/stagnation expected
buy
SNDL Inc.

Start price
Target price
Perf. (%)
€12.70
09.02.21
€10.00
3.15%
09.02.21

Probably not worthwhile Investment
High valuation
buy
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€11.10
09.02.21
-
09.02.22
-41.26%
07.03.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Some uniques
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€233.70
09.02.21
-
0.47%
09.02.21

buy
7C Solarparken

Start price
Target price
Perf. (%)
€4.59
09.02.21
-
09.02.22
-3.81%
10.12.21

buy
Ecograf Ltd.

Start price
Target price
Perf. (%)
€0.79
09.02.21
€1.00
09.02.22
-49.24%
10.02.22

Capable Management
Good culture
Innovative
Some uniques
buy
Lumentum Holdings Inc

Start price
Target price
Perf. (%)
€72.70
09.02.21
€100.00
09.02.22
13.56%
09.02.22

Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Future proof or reliable business model
buy
Keysight Technologies

Start price
Target price
Perf. (%)
€120.00
09.02.21
€180.00
09.02.22
23.75%
09.02.22

Could be very worthwhile Investment >20% year
Standard Investments for future growth
Growths faster than the competition
Some uniques
buy
Siemens AG

Start price
Target price
Perf. (%)
€131.94
09.02.21
-
09.02.22
2.33%
21.06.21

Could be very worthwhile Investment >20% year
High dividend yield expected
buy
wallstreet:online AG

Start price
Target price
Perf. (%)
€23.80
09.02.21
€25.00
7.98%
12.02.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Revenue growth >5% per year expected
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€235.45
09.02.21
€250.00
5.44%
16.02.21

Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Ocugen Inc.

Start price
Target price
Perf. (%)
€13.20
09.02.21
-
09.02.22
-73.73%
10.02.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Truist Financial Corp.

Start price
Target price
Perf. (%)
€43.80
08.02.21
-
08.02.22
6.39%
28.07.21

Very high dividend yield expected
Probably not worthwhile Investment
Business model of the past or high risk
buy
SNDL Inc.

Start price
Target price
Perf. (%)
€10.60
08.02.21
€10.00
19.81%
09.02.21

Probably not worthwhile Investment
High valuation